tiprankstipranks
Emyria Ltd (AU:EMD)
ASX:EMD
Australian Market
Holding AU:EMD?
Track your performance easily

Emyria Ltd (EMD) Share Price & Analysis

9 Followers

EMD Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

1.82%98.18%
― Other Institutional Investors
98.18% Public Companies and
Individual Investors

EMD FAQ

What was Emyria Ltd’s price range in the past 12 months?
Emyria Ltd lowest share price was AU$0.03 and its highest was AU$0.08 in the past 12 months.
    What is Emyria Ltd’s market cap?
    Currently, no data Available
    When is Emyria Ltd’s upcoming earnings report date?
    Emyria Ltd’s upcoming earnings report date is Feb 27, 2025 which is in 97 days.
      How were Emyria Ltd’s earnings last quarter?
      Emyria Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
        Is Emyria Ltd overvalued?
        According to Wall Street analysts Emyria Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Emyria Ltd pay dividends?
          Emyria Ltd does not currently pay dividends.
          What is Emyria Ltd’s EPS estimate?
          Emyria Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Emyria Ltd have?
          Emyria Ltd has 415,389,400 shares outstanding.
            What happened to Emyria Ltd’s price movement after its last earnings report?
            Emyria Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Emyria Ltd?
              Currently, no hedge funds are holding shares in AU:EMD
              ---

              Company Description

              Emyria Ltd

              Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. The anonymized data is commercialized as clinical evidence.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Race Oncology Ltd.
              Althea Group Holdings Ltd.
              Rhythm Biosciences Ltd.
              Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis